Vivos Therapeutics, Inc. Common Stock (VVOS)
Vivos Therapeutics, Inc. (VVOS) is a healthcare company focused on the diagnosis and treatment of sleep and airway-related disorders. It specializes in non-invasive, outpatient treatments for conditions such as sleep apnea through its proprietary Vivos System, which combines custom oral appliances with advanced digital technology. The company aims to provide minimally invasive solutions to improve patient outcomes related to sleep health and airway function.
Company News
Vivos Therapeutics reported Q2 2025 results with declining revenue of $3.8 million, a strategic shift towards medical provider alliances, and increased operating expenses following the Sleep Center of Nevada acquisition.
8 Out of 10 Newly Diagnosed OSA Patients Choose Oral Appliance Therapy Over CPAP and Preferred Vivos’ Flagship CARE Oral Medical Devices 5 to 1 Over Traditional Oral Appliances 8 Out of 10 Newly Diagnosed OSA Patients Choose Oral Appliance Therapy Over CPAP and Preferred Vivos’ Flagship CARE Oral Medical Devices 5 to 1 Over Traditional Oral A...
Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings shares jumped 34.1% to $6.09 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Vast Renewables Limited (NASDAQ...
Vivos Therapeutics jumped more than 270% after the FDA cleared the company's devices for severe sleep apnea.
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Vivos Therapeutics, Inc. (VVOS) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.